CCL22 and gastric cancer: The 16C/A SNP in CCL22 gene, causes an aspartate to alanine substitution in the CCL22 protein and likely the overexpression of CCL22.16 In a study by Wang et al. in Japan, an association between this polymorphism and susceptibility to gastric cancer was suggested both alone and in interaction with H. pylori.